Haemodynamic profiles of children with end-stage heart failure

被引:27
作者
Chen, Sharon [1 ]
Dykes, John C. [1 ]
McElhinney, Doff B. [1 ]
Gajarski, Robert J. [2 ]
Shin, Andrew Y. [1 ]
Hollander, Seth A. [1 ]
Everitt, Melanie E. [3 ]
Price, Jack F. [4 ]
Thiagarajan, Ravi R. [5 ]
Kindel, Steven J. [6 ]
Rossano, Joseph W. [7 ]
Kaufman, Beth D. [1 ]
May, Lindsay J. [8 ]
Pruitt, Elizabeth [9 ]
Rosenthal, David N. [1 ]
Almond, Christopher S. [1 ]
机构
[1] Stanford Univ, 750 Welch Rd,Suite 305, Palo Alto, CA 94304 USA
[2] Nationwide Childrens Hosp, Columbus, OH USA
[3] Childrens Hosp Colorado, Aurora, CO USA
[4] Texas Childrens Hosp, Houston, TX 77030 USA
[5] Boston Childrens Hosp, Boston, MA USA
[6] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA
[7] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[8] Primary Childrens Med Ctr, Salt Lake City, UT USA
[9] Univ Alabama Birmingham, Pediat Heart Transplant Study Grp, Birmingham, AL USA
关键词
Paediatric heart failure; Haemodynamics; IN-HOSPITAL MORTALITY; MEDICAL-MANAGEMENT; VENOUS CONGESTION; FILLING PRESSURES; TRANSPLANTATION; OUTCOMES; THERAPY; ASSOCIATION; DIAGNOSIS; SOCIETY;
D O I
10.1093/eurheartj/ehx456
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims To evaluate associations between haemodynamic profiles and symptoms, end-organ function and outcome in children listed for heart transplantation. Methods and results Children <18 years listed for heart transplant between 1993 and 2013 with cardiac catheterization data [pulmonary capillary wedge pressure (PCWP), right atrial pressure (RAP), and cardiac index (CI)] in the Pediatric Heart Transplant Study database were included. Outcomes were New York Heart Association (NYHA)/Ross classification, renal and hepatic dysfunction, and death or clinical deterioration while on waitlist. Among 1059 children analysed, median age was 6.9 years and 46% had dilated cardiomyopathy. Overall, 58% had congestion (PCWP>15mmHg), 28% had severe congestion (PCWP>22mmHg), and 22% low cardiac output (CI<2.2 L/min/m(2)). Twenty-one per cent met the primary outcome of death (9%) or clinical deterioration (12%). In multivariable analysis, worse NYHA/Ross classification was associated with increased PCWP [odds ratio (OR) 1.03, 95% confidence interval (95% CI) 1.01-1.07, P=0.01], renal dysfunction with increased RAP (OR 1.04, 95% CI 1.01-1.08, P=0.007), and hepatic dysfunction with both increased PCWP (OR 1.03, 95% CI 1.01-1.06, P < 0.001) and increased RAP (OR 1.09, 95% CI 1.06-1.12, P < 0.001). There were no associations with low output. Death or clinical deterioration was associated with severe congestion (OR 1.6, 95% CI 1.2-2.2, P=0.002), but not with CI alone. However, children with both low output and severe congestion were at highest risk (OR 1.9, 95% CI 1.1-3.5, P=0.03). Conclusion Congestion is more common than low cardiac output in children with end-stage heart failure and correlates with NYHA/Ross classification and end-organ dysfunction. Children with both congestion and low output have the highest risk of death or clinical deterioration.
引用
收藏
页码:2900 / 2909
页数:10
相关论文
共 50 条
  • [21] Survival and quality of Life for children with end-stage heart failure who are not candidates for cardiac transplant
    Sabati, Arash Alen
    Szmuszkovicz, Jacqueline R.
    Herrington, Cynthia
    Hermes, Mark
    Mahmoud, Hesham A.
    Wee, Choo Phei
    Starnes, Vaughn A.
    Menteer, JonDavid
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (07) : 906 - 911
  • [22] Cancer in End-Stage Heart Failure Patients Supported by Left Ventricular Assist Devices
    Loyaga-Rendon, Renzo Y.
    Inampudi, Chakradhari
    Tallaj, Jose A.
    Acharya, Deepak
    Pamboukian, Salpy V.
    [J]. ASAIO JOURNAL, 2014, 60 (05) : 609 - 612
  • [23] Successful Peritoneal Dialysis for the Treatment of Inotrope-Dependent End-Stage Heart Failure
    Sugiura, Emiyo
    Dohi, Kaoru
    Tanimura, Muneyoshi
    Kumagai, Naoto
    Ishikawa, Eiji
    Ito, Masaaki
    [J]. INTERNATIONAL HEART JOURNAL, 2019, 60 (05) : 1211 - 1218
  • [24] Comparative Survival and Cost-Effectiveness of Advanced Therapies for End-Stage Heart Failure
    Long, Elisa F.
    Swain, Gary W.
    Mangi, Abeel A.
    [J]. CIRCULATION-HEART FAILURE, 2014, 7 (03) : 470 - U155
  • [25] Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease
    Aldweib, Nael
    Broberg, Craig
    [J]. HEART FAILURE CLINICS, 2024, 20 (02) : 223 - 236
  • [26] Laparoscopic Bypass in Morbidly Obese Patient with End-Stage Heart Failure: Case Report
    Scheibe, Christian Lamar
    Pinto, Luis Eduardo Veras
    Valadao, Jose Aparecido
    de Oliveira, Caio Marcio Barros
    Moura, Ed Carlos Rey
    Campelo, Giuliano Peixoto
    de Lima, Roclides Castro
    Freire, Thyago Trisotto
    de Oliveira, Eduardo Jose Silva Gomes
    da Cunha Leal, Plinio
    [J]. OBESITY SURGERY, 2021, 31 (11) : 5059 - 5062
  • [27] End-stage heart failure in children or patients suffering from congenital heart disease: are new treatment options emerging?
    Miera, Oliver
    Potapov, Evgenij V.
    Berger, Felix
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2013, 43 (05) : 886 - 887
  • [28] Management and monitoring of haemodynamic complications in acute heart failure
    Aspromonte, Nadia
    Cruz, Dinna N.
    Valle, Roberto
    Ronco, Claudio
    [J]. HEART FAILURE REVIEWS, 2011, 16 (06) : 575 - 581
  • [29] Short-term mortality in end-stage heart failure patients
    Maria Verdu-Rotellar, Jose
    Calero, Esther
    Abellana, Rosa
    Verdu-Soriano, Jose
    Vinyoles, Ernest
    Luis del Val-Garcia, Jose
    Domingo, Mar
    Munoz, Miguel-Angel
    [J]. ATENCION PRIMARIA, 2020, 52 (07): : 477 - 487
  • [30] Ultrafiltration in End-Stage Heart Failure Too Little, Too Late?
    Weinrauch, Larry A.
    Desai, Akshay S.
    Lewis, Eldrin F.
    D'Elia, John A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (19) : 1913 - 1915